The market recovery continued with the Dow leaping 262 points to 17,672. Nasdaq jumped 89 points to 4,781.
On the upside
Shares of Twilio (NYSE: TWLO) surged again.
Upbeat clinical trial results from Tesaro (Nasdaq: TSRO) lifted shares of Clovis Oncology (Nasdaq: CLVS) which is developing a similar product.
Rising crude oil prices lifted shares of Vanguard Natural Resources (Nasdaq: VNR).
On the downside
RBC Capital Markets downgraded Esperion Therapeutics (Nasdaq: ESPR) from an Outperform rating to a Sector Perform rating.
Profit taking weighed down shares of 21Vianet Group (Nasdaq: VNET).
Kitov Pharmaceuticals (Nasdaq: KTOV) priced its offering of nearly 2.38 million units.
In the broad market, advancing issues outpaced decliners by a margin of nearly 7 to 1 on the NYSE and by more than 7 to 2 on Nasdaq. The broader S&P 500 surged 33 points to 2,069. Bitcoin lost $9 to $630.